Delivra Health Brands Inc (DHB.V)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of CA$10,000 in Delivra Health Brands Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Delivra Health Brands Inc (DHB.V) has returned -34.15% so far this year and -25.00% over the past 12 months.

Based on dividend-adjusted daily data since Mar 31, 2017, DHB.V's average daily return is +0.24%, while the average monthly return is -0.64%.

Historically, 30% of months were positive and 70% were negative. The best month was Jul 2023 with a return of +100.0%, while the worst month was Mar 2021 at -43.6%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 8 months.

On a daily basis, DHB.V closed higher 25% of trading days. The best single day was Feb 10, 2021 with a return of +104.2%, while the worst single day was Feb 11, 2021 at -39.8%.

Delivra Health Brands Inc has an annualized alpha of 74.37%, beta of 0.48, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since April 03, 2017.

• This stock participated in 175.28% of S&P 500 Index downside but only -38.73% of its upside — more exposed to losses than it benefited from rallies.
• Beta of 0.48 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

DHB.V ranks 27 for risk / return — below 27% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for Delivra Health Brands Inc (DHB.V) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Delivra Health Brands Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Delivra Health Brands Inc was 99.51%, occurring on Jun 30, 2023. The portfolio has not yet recovered.

The current Delivra Health Brands Inc drawdown is 99.33%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Delivra Health Brands Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Delivra Health Brands Inc is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.